MORGAN STANLEY PLC/CALL/MERCK & CO./135/0.1/20.12.24 Share Price

Warrant

DE000MB70R09

Delayed Börse Stuttgart 05:59:38 08/07/2024 pm IST
0.42 EUR +10.53% Intraday chart for MORGAN STANLEY PLC/CALL/MERCK & CO./135/0.1/20.12.24
Current month-29.63%
1 month-33.33%
Date Price Change
08/24/08 0.42 +10.53%
05/24/05 0.38 +5.56%
04/24/04 0.36 -5.26%
03/24/03 0.38 -17.39%
02/24/02 0.46 -8.00%

Delayed Quote Börse Stuttgart

Last update July 08, 2024 at 05:59 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN MB70R0
ISINDE000MB70R09
Date issued 06/06/2023
Strike 135 $
Maturity 20/12/2024 (165 Days)
Parity 10 : 1
Emission price 0.67
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.89
Lowest since issue 0.087
Spread 0.02
Spread %4.55%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
126.4 USD
Average target price
142.7 USD
Spread / Average Target
+12.84%
Consensus